PATENT CLAIM ANALYSIS

Application Number: 16060109
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "004800"]

Abstract:
The invention provides compositions and methods for inhibiting protein-protein interactions with cap-binding protein 80 (CBP80). In one embodiment, the invention provides compositions comprising linear and macrocylic peptides. In one embodiment, the invention provides methods for treating cancer, heart disease, autoimmune disorders, obesity, diabetes, or chronic inflammation disorders associated with the PGC1 family of co-activators.

Claim (Index 28):
A method for inhibiting the interaction between CBP80 and a PGC1 family of co-activator in a subject in need thereof, the method comprising administering to the subject an effective amount of a composition comprising the peptide of  claim 1 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.53488
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14398260', '15941030', '14800627', '14118545', '09825517']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8300074371624173
- 35 USC 102 Novelty (BERT): 0.562365521323466
- Combined Prediction Score: 0.8032432455785222
- Mean Citation Score: 553.978646
- Max Citation Score: 558.4818
- Similarity Product: 294.43399254298214

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test